Overexpression of Spondin-2 Is Associated with Recurrence-Free Survival in Patients with Localized Clear Cell Renal Cell Carcinoma.
Conclusion: SPON2 expression might function as a prognostic biomarker in patients with localized ccRCC.
PMID: 32952742 [PubMed - in process]
Source: Disease Markers - Category: Laboratory Medicine Tags: Dis Markers Source Type: research
More News: Cancer & Oncology | Carcinoma | Databases & Libraries | Genetics | Kidney Cancer | Laboratory Medicine | Renal Cell Carcinoma